Overview

The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study

Status:
Recruiting
Trial end date:
2021-01-31
Target enrollment:
Participant gender:
Summary
To determine patient preference and treatment outcomes with an intracanalicular dexamethasone (0.4mg) insert compared to standard steroid drop regimen in the contralateral eye following bilateral PRK surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Vance Thompson Vision
Collaborator:
Ocular Therapeutix, Inc.
Treatments:
Prednisolone